U.S. stocks had their worst day in more than a year as renewed pandemic fears roiled the market. It’s too early to say whether or not the Omicron variant will evade vaccines and lead to fresh lockdowns, but that didn’t stop investors from piling into more than a dozen stay-at-home standouts.
Barron’s screened for Nasdaq Composite stocks with market capitalizations of at least $4 billion that rose in 2020 but were down year to date through Wednesday. Of them, 14 familiar suspects rose in Friday trading, while the broader Nasdaq…
